Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Current Liabilities: 2012-2024

Historic Total Current Liabilities for Veracyte (VCYT) over the last 13 years, with Dec 2024 value amounting to $78.6 million.

  • Veracyte's Total Current Liabilities rose 2.62% to $72.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.2 million, marking a year-over-year increase of 2.62%. This contributed to the annual value of $78.6 million for FY2024, which is 28.40% up from last year.
  • Veracyte's Total Current Liabilities amounted to $78.6 million in FY2024, which was up 28.40% from $61.2 million recorded in FY2023.
  • Veracyte's 5-year Total Current Liabilities high stood at $78.6 million for FY2024, and its period low was $16.8 million during FY2020.
  • In the last 3 years, Veracyte's Total Current Liabilities had a median value of $62.6 million in 2022 and averaged $67.5 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first decreased by 3.94% in 2020, then skyrocketed by 282.28% in 2021.
  • Over the past 5 years, Veracyte's Total Current Liabilities (Yearly) stood at $16.8 million in 2020, then skyrocketed by 282.28% to $64.2 million in 2021, then dropped by 2.40% to $62.6 million in 2022, then declined by 2.19% to $61.2 million in 2023, then rose by 28.40% to $78.6 million in 2024.